FSP and COVID-19: Impact on Clinical Trial Development


In an already challenging clinical trial forecasting environment, the COVID era has exacerbated on an unprecedented scale. Functional service provider(FSP) models, designed to help sponsors efficiently and cost-effectively manage workforce needs acros clinical portfolios, can be a strategic asset during the corona virus pandemic.

experts representing monitoring and data operations will discuss how FSP models can often work better than traditional approaches when managing unexpected circumstances. Discussion will also include current COVID-19 examples to illustrate speed and execution flexibility.